Page 128 - Portuguese Journal - SPORL - Vol 61. Nº1
P. 128

Figure 5
          Type of curative treatment






























          Time intervals                                    post-COVID-19  period  (A=9;  B=5)  (p=0.009).
          With regard to the analyzed time intervals, as    However, in the subgroup of patients who
          described in Figure 6, the median duration        underwent     non-surgical   treatment,    the
          of symptoms in the post-COVID-19 group            median time until the start of treatment was
          (B=12.9) was longer than that in the pre-         similar in both periods (A=7.5; B=7) (p=0.317).
          COVID-19 group (A=8.6), and the difference was    Moreover, there was a statistically significant
          statistically significant (p=0.009). With regard   negative correlation between the tumor stage
          to the timing of referral and time interval       and  time  interval  between  the  first  medical
          between the ORL consultation and histological     evaluation and treatment initiation (r=-0.195; p
          diagnosis, there were no differences between      = 0.019).
          the two groups. On the other hand, the time
          interval between the diagnosis and the start      Prognosis
          of  treatment  was  significantly  shorter  in  the   The time interval (in months) between the
          post-COVID-19 group (B=6) than in the pre-        histological  diagnosis  and  date  of  death  for
          COVID-19 group (A=8) (p=0.008). The analysis      each patient was recorded. The proportion of
          of assistance-related delay (time elapsed since   patients with survival ≤ 12 months was similar
          the first medical evaluation until the start of   in both groups (A=28.6%; B=29%) (p=0.95).
          treatment)  showed  no  differences  between
          the two groups (A=13.5; B=13) (p=0.523).          Discussion
          Overall, the median time from symptom             The timely diagnosis and treatment of
          onset to treatment initiation was 20.6 weeks in   patients with HNC are associated with a better
          the pre-COVID-19 group and 24.1 weeks in the      long-term prognosis . The diagnosis requires
                                                                                 7
          post-COVID-19 group; however, the difference      a biopsy (often performed in the operating
          was not statistically significant (p=0.141).      room) as well as complementary diagnostic
          As shown in Table 3, in the subgroup of           tools to determine the tumor stage. The
          patients who underwent surgery, there was         involvement of a multidisciplinary team in this
          a  statistically  significant  reduction  in  the   complex process is essential for the optimal
          number of weeks that elapsed between the          clinical management of patients with HNC.
          histological diagnosis and intervention in the    However, the restrictions imposed by the



      128  Portuguese Journal of Otorhinolaryngology - Head and Neck Surgery
   123   124   125   126   127   128   129   130   131   132   133